Skip to main content
Displaying 1 - 9 of 9
Display:
12
24
48
Metabolism, Alcohol & Toxicity
1
Novo Nordisk: "Walking the clinical care pathway for NASH: learnings from implementation" - EASL Congress 2023
View
Immune-Mediated and Cholestatic Diseases
1
Mirum Pharmaceuticals, Inc: "Meet the Experts in Cholestatic Liver Disease" - EASL Congress 2023
View
Metabolism, Alcohol & Toxicity
1
Novo Nordisk and Echosens: "Clinical challenge: Updates on the non-invasive toolbox for NASH and Fibrosis" - EASL Congress 2023
View
Immune-Mediated and Cholestatic Diseases
6
Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023
View
Immune-Mediated and Cholestatic Diseases
6
Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023
View
Immune-Mediated and Cholestatic Diseases
6
Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023
View
Immune-Mediated and Cholestatic Diseases
6
Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023
View
Immune-Mediated and Cholestatic Diseases
6
Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023
View
Immune-Mediated and Cholestatic Diseases
6
Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023
View
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy